BKV LT-ag peptide LLLIWFRPV (HLA-B*0201)IBA Lifescience Kontakt z doradcą
BKV LT-ag peptide LLLIWFRPV (HLA-B*0201) is a single peptide for stimulation of T cells. The peptide from BK polyomavirus (BKV) large tumor antigen (LT-ag) is synthesized as it is presented by the MHC class I HLA-B*0201 allele and can be used for targeted in vitro generation and expansion of antigen-specific CD8+ T cells. The peptides were purified by HPLC using a water and acetonitrile gradient and are endotoxin-free.
- Form: Lyophilized powder
- Peptide Sequence: LLLIWFRPV
- Possible Application: T cell stimulation
- Purity: > 85%
- Sterility: Sterile